Share This Page
Drug Price Trends for FT INFANT PAIN-FEVER
✉ Email this page to a colleague

Average Pharmacy Cost for FT INFANT PAIN-FEVER
Drug Name | NDC | Price/Unit ($) | Unit | Date |
---|---|---|---|---|
FT INFANT PAIN-FEVER 160 MG/5 | 70677-1253-01 | 0.04357 | ML | 2025-01-22 |
FT INFANT PAIN-FEVER 160 MG/5 | 70677-1253-01 | 0.04350 | ML | 2024-12-18 |
FT INFANT PAIN-FEVER 160 MG/5 | 70677-1253-01 | 0.04337 | ML | 2024-11-20 |
FT INFANT PAIN-FEVER 160 MG/5 | 70677-1253-01 | 0.04552 | ML | 2024-10-23 |
FT INFANT PAIN-FEVER 160 MG/5 | 70677-1253-01 | 0.04552 | ML | 2024-09-18 |
FT INFANT PAIN-FEVER 160 MG/5 | 70677-1253-01 | 0.05137 | ML | 2024-08-21 |
FT INFANT PAIN-FEVER 160 MG/5 | 70677-1253-01 | 0.05662 | ML | 2024-07-17 |
>Drug Name | >NDC | >Price/Unit ($) | >Unit | >Date |
Market Analysis and Price Projections for FT Infant Pain-Fever Medications
Introduction
FT Infant Pain-Fever medications, typically consisting of acetaminophen and ibuprofen, are crucial for managing pain and fever in infants and children. The market for these medications has seen significant fluctuations and growth, driven by various factors including demand, technological innovations, and regulatory changes.
Current Market Scenario
In recent years, the market for antipyretic drugs for children, including FT Infant Pain-Fever medications, has experienced notable trends and challenges.
Supply Chain and Availability
In late 2022 and early 2023, Canada faced a significant shortage of infant and children's acetaminophen and ibuprofen products. However, through increased domestic production and imports, the supply began to improve by March 2023, and by April 2023, these products were readily available again[1].
Market Size and Growth
The global market for antipyretic drugs for children is substantial and growing.
Global Market Size
The antipyretic drugs for children market was valued at $3.02 billion in 2023 and is projected to grow to $3.21 billion in 2024 at a CAGR of 6.4%. By 2028, the market is expected to reach $4.16 billion with a CAGR of 6.7%[3].
Regional Market
North America was the largest region in the antipyretic drugs for children market in 2023, while the Asia-Pacific region is expected to be the fastest-growing in the forecast period[3].
Drivers of Market Growth
Several factors are driving the growth of the antipyretic drugs market for children.
Increasing Awareness and Demand
Growing awareness of pediatric health and the increasing incidence of fever-related illnesses in children worldwide are key drivers. Rising healthcare expenditures among families to treat common childhood fevers and increasing access to over-the-counter antipyretic drugs in emerging markets also contribute to market growth[3].
Technological Innovations
Technological innovations in pediatric drug formulations, such as the development of medicine gummy bites, are enhancing the ease of administration and improving compliance among young patients. For example, DrKids launched an acetaminophen gummy bite in October 2023, offering a child-friendly pain and fever relief alternative[3].
Growing Birth Rates
Growing birth rates, driven by improved healthcare access, economic conditions, and higher fertility rates in certain regions, are expected to propel the demand for antipyretic drugs for children. A larger population of infants and young children requires more medical care, including fever management[3].
Price Projections
The pricing of FT Infant Pain-Fever medications can be influenced by several factors, including production costs, regulatory changes, and market demand.
Production Costs and Supply Chain
The cost of producing these medications can vary based on raw material prices, manufacturing costs, and supply chain efficiencies. The recent shortage in Canada highlighted the importance of a stable supply chain in maintaining prices. With the supply now stabilized, prices are expected to remain relatively stable or decrease slightly due to increased competition and improved production efficiencies[1].
Market Competition
The antipyretic drugs market is competitive, with several major companies operating in the space. This competition can drive prices down as companies strive to offer competitive pricing while maintaining profitability. The introduction of innovative products, such as gummy bites, may also influence pricing strategies as companies balance innovation with affordability[3].
Regulatory Environment
Regulatory changes and health guidelines can significantly impact the market and pricing of FT Infant Pain-Fever medications.
Health Guidelines and Recommendations
Healthcare guidelines and recommendations play a crucial role in the use and prescription of these medications. For instance, evidence-based care process models have improved the management of febrile infants, reducing unnecessary treatments and costs. Such guidelines can influence the demand and pricing by ensuring that medications are used judiciously and effectively[2].
Consumer Trends
Consumer trends are shifting towards safer, more convenient, and personalized treatments.
Shift to Natural and Herbal-Based Antipyretics
There is a growing trend towards natural and herbal-based antipyretic drugs for children, driven by consumer preference for safer and more natural alternatives. This shift may influence pricing as companies invest in research and development to meet these consumer demands[3].
Telemedicine and Remote Consultations
The growing adoption of telemedicine platforms is changing how parents access pediatric consultations for fever management. This trend can affect pricing by reducing the need for in-person consultations and potentially lowering the overall cost of care[3].
Key Takeaways
- The global market for antipyretic drugs for children is growing, driven by increasing awareness of pediatric health, technological innovations, and growing birth rates.
- The supply chain for FT Infant Pain-Fever medications has stabilized after recent shortages.
- Prices are expected to remain stable or decrease slightly due to improved production efficiencies and market competition.
- Regulatory changes and health guidelines continue to influence the market and pricing.
- Consumer trends are shifting towards safer, more convenient, and personalized treatments.
FAQs
1. What was the impact of the recent shortage of acetaminophen and ibuprofen in Canada? The recent shortage in Canada led to significant efforts to increase domestic production and import foreign-authorized products, resulting in improved supply by March 2023 and full availability by April 2023[1].
2. How is the global market for antipyretic drugs for children expected to grow? The global market is expected to grow from $3.02 billion in 2023 to $3.21 billion in 2024 at a CAGR of 6.4%, and reach $4.16 billion by 2028 at a CAGR of 6.7%[3].
3. What are the key drivers of the antipyretic drugs market for children? Key drivers include increasing awareness of pediatric health, growing incidence of fever-related illnesses, rising healthcare expenditures, and technological innovations in drug formulations[3].
4. How are consumer trends influencing the market for FT Infant Pain-Fever medications? Consumers are increasingly preferring natural and herbal-based antipyretics, and there is a growing adoption of telemedicine platforms for fever management, which is driving innovation and potentially affecting pricing[3].
5. What role do regulatory changes and health guidelines play in the market? Regulatory changes and health guidelines ensure that medications are used judiciously and effectively, influencing demand and pricing by promoting evidence-based care and reducing unnecessary treatments[2].
Sources
- Health Canada: Supply of acetaminophen, ibuprofen and cough and cold medicines.
- PubMed: Costs and infant outcomes after implementation of a care process model.
- The Business Research Company: Antipyretic Drugs For Children Global Market Report 2024.
- GMI Insights: Acetaminophen Market Size & Share Report, 2023 – 2032.
- Market Research Future: Infant Fever Sticker Market Size, Share, Industry Growth, Forecast.
More… ↓